Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Kinetic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Co(III) catalyzed route for Oteseconazole offers high ee value and safety. Reliable supply chain partner for scalable antifungal intermediate manufacturing.
Patent CN106520651A details enzymatic L-norvaline production. High purity, scalable process offers supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN102925528B reveals a novel nitrilase-catalyzed route for high-purity levo-praziquantel intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101622239A reveals a high-yield resolution method for homocysteine-gamma-thiolactone using chiral acids and aromatic aldehydes, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Patent CN106397117A details a novel enzymatic resolution process yielding high-purity chiral alcohols with significant supply chain and cost advantages for global buyers.
Patent CN1993472A details a lipase-catalyzed route for chiral 3-hydroxy acids, offering cost reduction in API manufacturing and superior supply chain reliability.
Patent CN1177958A details a lipase-catalyzed resolution of pyrazole carbinols. Discover cost-effective, high-purity manufacturing solutions for analgesic intermediates.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN112481320B details a novel recombinant lactamase for producing optically pure (-)-γ-lactam. This breakthrough offers superior stability and stereoselectivity for antiviral drug synthesis.
Patent CN110066835B details a novel lipase resolution process for agrochemical intermediates, offering superior enantioselectivity and cost-effective manufacturing solutions.
Patent CN103013945B details a novel epoxide hydrolase mutant enhancing hydrolytic activity and enantioselectivity for beta-blocker synthesis, offering significant cost and supply chain advantages.
Patent CN112813131A reveals a high-efficiency carboxylesterase for producing Edoxaban intermediates with superior substrate tolerance and optical purity.
Patent CN111500652A reveals a novel enzymatic dynamic kinetic resolution for florfenicol. Discover cost-effective, high-purity veterinary drug intermediate manufacturing solutions.
Patent CN118056823A reveals a scalable route for high-purity Platinib intermediates. This process eliminates chromatography, ensuring cost reduction and supply reliability for pharmaceutical manufacturers.
Patent CN110055297B details a novel esterase for resolving (R,S)-5-caprolactone with >98% ee. Discover cost-effective biocatalytic routes for high-purity flavor intermediates.
Novel catalytic route for posaconazole intermediate ensuring high purity and cost efficiency for pharmaceutical supply chains globally. This report analyzes patent CN115448911B for strategic sourcing.
Patent CN100558905C details a lipase-based resolution for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104263798A details high-purity S-1-aminotetralin production via dynamic kinetic resolution offering significant supply chain and cost advantages.
Patent CN118852050B reveals a novel levamisole intermediate synthesis avoiding DMSO. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.